JANE STREET GROUP, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 1 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$48,000
-85.5%
92,306
-78.9%
0.00%
Q2 2020$331,000
-0.3%
436,708
+115.6%
0.00%
-100.0%
Q2 2019$332,000
+1560.0%
202,580
+1682.6%
0.00%
Q1 2019$20,000
-78.3%
11,364
-74.4%
0.00%
Q2 2018$92,00044,3410.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$42,747,00027.52%
ESSEX INVESTMENT MANAGEMENT CO LLC 637,696$650,0000.13%
Integrated Advisors Network LLC 478,630$488,0000.10%
BARD ASSOCIATES INC 79,400$81,0000.06%
Kore Private Wealth LLC 202,366$206,0000.05%
HighTower Advisors, LLC 5,284,688$5,390,0000.04%
NEXPOINT ASSET MANAGEMENT, L.P. 158,520$162,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 509,200$519,0000.01%
Summit X, LLC 25,500$26,0000.01%
American Portfolios Advisors 111,687$113,9210.01%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders